The Patent Finder

Exelixis Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Exelixis Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Exelixis Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,531,644Methods for identifying anti-cancer drug targets
Term ended
Term ended Jan 20, 2020 · USPTO record
Term endedTerm ended Jan 20, 2020USPTO record
US 6,511,824Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use
Term ended
Term ended Mar 17, 2019 · USPTO record
Term endedTerm ended Mar 17, 2019USPTO record
US 6,468,770Nucleic acids and proteins of D. melanogaster insulin-like genes and uses thereof
Term ended
Term ended Nov 30, 2018 · USPTO record
Term endedTerm ended Nov 30, 2018USPTO record
US 7,125,687Presenilin enhancers assays
Lapsed on the fee record
Ended Oct 24, 2018 · USPTO record
Lapsed on the fee recordEnded Oct 24, 2018USPTO record
US 6,218,526Polynucleotide encoding human netrin-1
Term ended
Term ended Aug 20, 2018 · USPTO record
Term endedTerm ended Aug 20, 2018USPTO record
US 6,225,285Semaphorin K1
Term ended
Term ended Mar 11, 2018 · USPTO record
Term endedTerm ended Mar 11, 2018USPTO record
US 6,781,028Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism
Lapsed on the fee record
Ended Aug 24, 2016 · USPTO record
Lapsed on the fee recordEnded Aug 24, 2016USPTO record
US 6,703,491Drosophila sequences
Formerly held
Lapsed on the fee record
Ended Mar 9, 2016 · USPTO record
Lapsed on the fee recordEnded Mar 9, 2016USPTO record
US 6,627,746Nucleic acids and proteins of C. elegans insulin-like genes and uses thereof
Formerly held
Lapsed on the fee record
Ended Sep 30, 2015 · USPTO record
Lapsed on the fee recordEnded Sep 30, 2015USPTO record
US 6,583,277Semaphorin K1
Lapsed on the fee record
Ended Jun 24, 2015 · Medium confidence
Lapsed on the fee recordEnded Jun 24, 2015Medium confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited